Professional Documents
Culture Documents
Palm Phenolics in
Healthcare
Dr. Robert P. Weinberg, D.O., J.D.
Research Scientist
Biomaterials Science and Engineering Lab
M.I.T.
Herbal Medicine
7000 plants have medicinal applications
25% of “modern” prescription drugs have
botanical origins
Drug = drogge = to dry
Botanical supplement sales= US$20+
billion/yr
Western Herbalists use “simples”=1 herb
Chinese and ayurvedic use many blended
together
What is a Dietary
Supplement?
Definition: (Sec 3.)
A product (other than tobacco) intended
to supplement the diet that bears or
contains one or more of the following
dietary ingredients
Vitamins
Minerals
Herbs or other botanicals
Amino acids
Concentrate, metabolite, constituent,
extract or combination of above listed
ingredients
3
Dietary
Supplements
Traditionally defined as products made of
one or more essential nutrients such as
vitamins, minerals, and proteins, but…
DSHEA broadened definition to include
almost any product intended for
ingestion as a supplement to the diet
Must be identified on label as a D/S
4
Dietary
Supplements
Distinguished from Drugs:
Drug = article intended to diagnose,
cure, mitigate, treat, or prevent
disease
Both intended to affect structure and
function of body
Drug must undergo FDA approval after
clinical studies to determine effectiveness
and safety
D/S = no pre-market testing
5
Dietary
Supplements
Distinguished from Foods:
Foods not intended to affect structure
and function
D/S intended only to supplement diet
Not represented for use as
conventional food
Not intended as sole item of a
meal or the diet”
6
H e rb a lPre p a ra tio n s
Te a s, in fu sio n s, d e co ctio n s – m a d e b y
ste e p in g a n d so a kin g h e rb in w a te r fo r a
fe w m in u te s
Tin ctu re s – h e rb is so a ke d in a lco h o l,
g lyce rin o r a n a lco h o l- w a te r
co m b in a tio n
E xtra ct – a filte re d o r d istille d tin ctu re
Ta b le ts a n d ca p su le s – d ryin g th e h e rb ,
p o w d e rin g it sh a p in g it in to p ills
To p ica ls – h e rb a d d e d to e m o llie n t
In je ctio n s – ve ry ra re , u su a lly o f a
St. John’s Wort
(Hypericum)
Uses: Depression, Anxiety, Antiviral Agent
#1 Anti-depressant in Germany
Major action is the inhibition of seratonin,
norepinephrine and dopamine uptake and
down-regulation of receptors, standardized on
hypericin content
Likely safe in usual doses, in high
doses can cause severe photogenic
skin reactions
St. John’s Wort
Dosage: Daily dose of 900 mg of SJW extract
(standardized to 0.3% hypericin) found to be
equivalent to 20 mg fluoxetine
Doses up to 1800 mg tolerated in severe
depression
Likely effective in mild to moderate depression
Possibly ineffective as antiretroviral agent (and
may decrease effectiveness of HIV agents)
Saint John’s Wort
Contraindications: Severe depression with
akinetic mutism, suicidal tendencies, severe
agitation, hypersensitivity and pregnancy
(estrogen effects)
Precautions: photosensitivity
Interactions: May precipitate hypertensive crisis
with MAO inhibitors (Mueller & Shaefer,1996)
May induce “serotonin syndrome” with SSRI’s a
with Triptans
Interferes with cyclosporine, may cause transpla
rejection
May cause hypertension with tyramine containin
foods
Safe with benzodiazapines
Ginkgo biloba
Uses: Dilates arteries, capillaries and veins
Used to increase peripheral blood flow and
improve intermittent claudication Used to
treat varicosoities, cerebral vascular
insufficiency, dementia, vertigo, and SSRI-
induced sexual dysfunction
$1 billion in US sales annually
Most frequently prescribed herb in Germany
Ginkgo biloba
Likely safe when used in appropriate doses
for up to a year, unsafe intravenously
Possibly effective in dementias (equivalent
to a six month delay in disease
progression), in improving cognitive
function in normal adults and in improving
pain free walking distances
Ineffective for memory enhancement,
ADHD, depression
Ginkgo biloba
Precautions and interactions: Ginkolideis a selective
antagonist of platelet aggregation. Case reports of
subdural hematoma and spontaneous bleeding with
ASA use. Reports of GI disturbances and CNS symptom
Any part of
a plant
used for its
medicinal ,
flavoring , or
fragrant
property
Why People Use Them?
Consumer Lab Survey (54% had multiple
reasons)
General Health – 67%
Colds – 53%
Osteoarthritis – 39%
Energy Enhancement – 37%
Cholesterol Lowering – 29%
Cancer Prevention – 28%
Allergies – 27%
Weight Management – 25%
Herbal medicines are rapidly
increasing in
economic importance
US$ 60 000 million world
market sales for herbal
Other medicines
Countries
(including raw materials )
China
Japan
Western
Europe Canada
USA
traditional Myanmar
70%
medicine for 70%
primary care Rwanda 60%
Tanzania 60%
Uganda
Populations in Germany 80%
developed 70%
countries who have Canada
used complementary France
49%
and alternative 48%
medicine at least Australia
once 42%
USA
Sources: Eisenberg DM et al. 1998; Health Canada, 2001;Myanmar and Mali government in 2008,
BMJ in 2003.
10/13/10
China + India = >25% Total World Exports Value
2 0 0 6 T o ta l
S e le c te d H
Summary of South American Botanical Exports
2008 Volume (kg) and Value (USD)
S o u th A m e ri
B R A Z IL
A R G E N T IN A
Evaluation of efficacy of herbal
medicines
T h e co m b in a tio n R e m o vin g a n y o n e
o f 4 p la n ts o f th e 4 p la n ts
cre a te s a w e a ke n s th e
p o w e rfu l e ffe ctive n e ss o f
syn e rg y fo r th e fo rm u la
m a xim u m
a n ti-tu m o u r
e ffe ct
Worldwide Sales of Leading Therapeutic Classes
(in BILLIONS of $USD) and Percent Growth (in local currency)
29
European Herbals Market
Total Sale of Herbal Medicines , 2003 = € 3 . 7
billion
2% 11%
GERMANY
2% FRANCE
2%
ITALY
39%
4% POLAND
UK
5%
SPAIN
6% SWITZERLAND
BELGIUM
8% 21% NETHERLANDS
OTHERS
660
640 649
637
620
600
580
571
560
540
520
1999 2000 2001
The 8 member states are : the Kingdom of Bhutan, Canada, the
33
G lo b a lM a rke t o f S u p p le m e n ts in
6.Cancer Prevention
ds
is
ies
ri t
lth
n
t
l
t
Co
en
tio
rg
en
ri n
th
ea
em
le
Ar
em
en
we
lH
Al
7.Allergies
nc
ev
ag
Lo
ra
Pr
ha
an
ne
ol
En
er
tM
Ge
er
nc
st
y
gh
rg
Ca
le
ei
e
o
En
W
Ch
8.Weight Management
Categories of Pharmaceutical Products - 1
40
Categories of Pharmaceutical
Products - 2
41
W hy do you use them?
0%
G eneral Health
C olds 67% 0%
Arthritis 33% 0%
0%
Energy Enhancem ent 50 %
0%
Cholesterol Lowering
0%
Cancer Prevention
Allergies0% 50 %
0%
Weight M anagem ent
Fe m ale M ale
4 Basic Building Blocks of
Biosynthesis
1. Acetyl coenzyme A
Major role in the synthesis of phenols,
prostaglandins, macrolide antibiotics, and various
fatty acids and their derivatives.
2. Deoxyxylulose phosphate
Together with mevalonic acid is responsible for a
vast array of terpenoids and other steroids.
3. Mevalonic acid
Major precursor of cholesterol and other sterols.
4. Shikimic acid
Major precursor of phenylalanine, tyrosine, and
tryptophan and, hence, the majority of plant
alkaloids. Also involved in the biosynthesis of
lignin, flavonoids, and other aromatics.
43
Figure 5
Medicare IHS 6 %
58 % Health
Discretionary FDA 3 %
Programs NIH
9% 54 % SAMHSA
6%
Medicaid
CMS - PM
33 % 6%
SCHIP
1% OS - DM
6%
Total = $592 Total = $52 . 6
Billion Billion
Notes: Totals do not include funding for the Administration on Children and Families,
the Administration on Aging and Program Support Center. AHRQ funding is entirely
through transfers from other HHS agencies. Totals do not add to 100% due to rounding.
SOURCE: HHS, Budget in Brief FY 2006, February 2005.
CAM use in cancer and HIV
patients
70
Massage therapy
60
50 Acupuncture
40
Chiropractic
30
20 Mind/body
therapy
10
Herbal
0
Cancer HIV patients Any CAM use
patients on HAART
N=356 N=118
80
70
60
50 P la c e b o
Percent
40 T re a tm e n t
30
20
10
0
N o d ia b e te s T y p e 2 d ia b e te s m e llitu s
As Defined by NCCAM
CAM Therapies
http://nccam.nih.gov/news/camsurvey_fs1.htm#domain
CAM Therapies
Pediatric Use of CAM
Asthma 80% Reznik, 2003
(Bronx, NY)
Adolescents 54-69% Wilson, 2002 (NY)
Braun, 2005 (MN)
Special Needs 64% Sanders, 2003
(Tucson, AZ)
Rheumatology 64% Hagen, 2003
(Toronto)
ADHD 54% Chan et al, 2003
(Boston Children’s)
Emergency13-45% Losier, 2005 (Ottawa)
Lanski, 2003 (Atlanta)
Pediatric Use of CAM
Oncology 47-84% McCurdy, 2003 (WFU)
Neuhouser, 2001 (Seattle)
Kelly, 2000 (NYC)
Cerebral Palsy 56% Hurvitz, 2003
Ann Arbor, MI
IBD 41% Heuschkel, 2002
London, Boston, Detroit
Autism Spectrum 30% Levy, 2003
CHOP, PA
Preoperative 29.5% Lin, 2004
Boston Children’s
Primary Care 12-21% Sawni, 2002 (Detroit)
Ottolini, 2001 (Wash D.C.)
Use of Herbs- Evidence?
Alternative Health supplement of the 2002
National Health Interview Survey: data on
10 common herbs
Of 30,616 adults, 19% used herbs in past
12 mo, 57% for a specific condition
Approximately 2/3 used herbs (except
Echinacea) not in accordance with
evidence based indications
Mayo Clin Proc, May 2007;82(5): 561-566
Why Should We Care?
30,000 herbs on the market currently
Estimates of $30-40 billion dollars spent
annually Eisenberg D. et al, JAMA, Nov 11, 1998(18) 1569-
1575
E ise n b e rg D . e t a l, JA M A , N o v 1 1 , 1 9 9 8 ( 1 8 ) 1 5 6 9 -
1575
Nutritional Supplement
Recommendations
from Sloan-Kettering
20+ billion dollars are spent each
year in the
USA on vitamins and nutritional
supplements
Anti-oxidants are highly marketed and
are
of uncertain benefit
Wheat Grass, Gogi, Noni, Acai,
Pomegranate,
Green Tea, Reveratrol, Vitamins A, C
and E
have not proven to be of any real
benefit
H IG H LE V E LS O F
A N T I- O X ID E N T S
PR O TEC T C A N C ER
C E LLS
A S W E LL A S
H E A LT H Y C E LLS !
Impact of CAM
CDC Report (2004)
36% of adults used some form of CAM
55% CAM + conventional treatments
26% used CAM because a medical
professional suggested it
$36-47 billion on CAM therapies in 1997
$5 billion on herbal remedies
JAMA (1998)
12.1% of population use herbal medicine
Impact of CAM
According to the National Health Statistics Report of
*Barnes PM,et al. Complementary and alternative medicine use among adults: United States 2002; CDC
Diseases and Condition
2007
1.Back pain
2.Neck pain
3.Joint pain or stiffness
4.Arthritis
5.Other, specify
6.Anxiety
7.Cholesterol
8.Head or Chest Cold
Top 5 CAM Therapies
2002
1.Natural products, dietary supplements
2.Deep breathing exercises
3.Meditation
4.Chiropractic
5.Yoga
*Barnes PM,et al. Complementary and alternative medicine use among adults: United States 2002; CDC
Top 10 Supplements
2002
1.Echinacea 6.St. John’s Wort
2.Ginseng 7.Peppermint
3.Ginkgo biloba 8.Fish oil/Omega 3
4.Garlic 9.Ginger
5.Glucosamine 10.Soy
*Barnes PM,et al. Complementary and alternative medicine use among adults: United States 2002; CDC
Top 10 Supplements
2007
1.Fish Oil or Omega 3 or 6. Combination herb pill
DHA 7. Ginkgo biloba
National Health
Expenditures
as a % of GDP
Oil Palm Phenolics
Dr. Robert Weinberg
Research Scientist, MIT
September 27, 2010
OPP lowers Blood
Pressure
Hypertension is a major cause of morbidity and
mortality globally, affect 250 million people
OPP significantly blocks the rise in blood
pressure in rats deficient in NO
This protection of blood pressure was dose-
dependent
Current global expenditures for anti-
hypertensive treatment are approximately
US$
Effect of OPP on Blood
Pressure
OPP reduced risk of Ventricular Fibrillation
(VF)